Markets kick off trading erasing some of the gains of the last few days, but where are stocks going for the long term? Washington Crossing Advisors' Matthew Battipaglia says economic and earnings fundamentals will drive markets for patient investors.
We also take a look at recent results from Coach parent Tapestry and Michael Kors. Both companies reported better-than-expected results for the holiday quarter, driving shares higher. We take a look at if that means they'll be able to weather the changing retail landscape.
And Blue Apron shares popped after earnings Tuesday morning. The meal-kit delivery company said revenues fell less than expected in the latest quarter and that it upped spending on marketing. But is this enough to keep the company afloat, or will it have to find a buyer?
Gift cards make great stocking stuffers — just as long as you don't stuff them in a drawer and forget about them after the holidays.
Big Business This Week is a guided tour through the biggest market stories of the week, from winning stocks to brutal dips to the facts and forecasts generating buzz on Wall Street.
Bristol Myers Squibb agreed to buy schizophrenia drug maker Karuna Therapeutics in a $14 billion deal.
Supermarket chain Ralphs is facing a new lawsuit from the state of California.
Shake Shack is giving out free fried chicken sandwiches, bacon cheese fries and milkshakes nationwide.
The IRS is announcing a voluntary disclosure program.
Lionsgate announced its studio division is going to spin off in a merger with Screaming Eagle Acquisition Corp., which is a special purpose acquisition company.
A new report suggests that it's getting more difficult for an average American to afford a home.
The Food and Drug Administration warned consumers about a copycat version of the diabetes drug Ozempic.
Tesla is reportedly moving forward with its plan to make energy shortage storage batteries in China.
